{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T14:06:08Z","timestamp":1781618768946,"version":"3.54.5"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["This study was partially funded by Italian Ministry of Health - Current research IRCCS"],"award-info":[{"award-number":["This study was partially funded by Italian Ministry of Health - Current research IRCCS"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Primary care paediatricians play a key role in the diagnosis, management, and prevention of bronchiolitis, but data on their clinical practices remain limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>An online survey was conducted via email by the Lombardy section of the Italian Primary Care Paediatrics Society (SICuPP) between January 1 and April 30, 2025. Primary care paediatricians were invited to participate via email. Associations were assessed using the chi-square or Fisher\u2019s exact test. Multivariable logistic regression identified factors associated with the prescription of antibiotics, corticosteroids, and bronchodilators\u2014three drug categories commonly used in bronchiolitis despite not being recommended by current guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The response rate was 28.8%, yielding 306 valid responses. Most respondents (62.1%) had over 20 years of clinical experience. Diagnostic criteria varied: 42.8% used 12 months as the upper age limit, 42.2% used 24 months, and 5.6% applied no age limit. Diagnostic approaches differed, with 45.1% relying on wheezing\/grunting and 36.9% on wet sounds. Pulse oximetry was always used by 39.5%, and 67.9% never used rapid viral tests. Bronchodilators and steroids were recommended by 37.6% and 32.3%, respectively. Antibiotics were prescribed in 30.1% of cases with poor general condition and 18.6% with fever. Nirsevimab prophylaxis was well accepted (96.4%), with high caregiver compliance (97.7%). Paediatricians diagnosing bronchiolitis up to 36 months were less likely to report never prescribing antibiotics (OR 0.13, 95% CI 0.02\u20130.51), whereas those relying on widespread sounds were more likely than those using grunting or wheezing (OR 2.42, 95% CI 1.23\u20134.83). Bronchodilator use was lower with diagnosis based on widespread sounds (OR 0.38, 95% CI 0.18\u20130.77). Steroid use was higher without an age limit (OR 3.09, 95% CI 1.09\u20139.25) and lower with widespread sounds (OR 0.31, 95% CI 0.13\u20130.66).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This first Italian survey on bronchiolitis management in primary care reveals substantial variability in diagnostic and treatment practices. Diagnostic inconsistency is associated with non-guideline-recommended prescribing. Standardized diagnostic criteria are needed. Nirsevimab prophylaxis was widely accepted, supporting its continued use to reduce the burden of bronchiolitis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13052-025-02152-y","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T09:38:44Z","timestamp":1763545124000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Diagnosis, management, and prevention of bronchiolitis in primary care: a survey of Italian family paediatricians"],"prefix":"10.1186","volume":"51","author":[{"given":"Marina","family":"Picca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Pezzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Baggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Manzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Mezzopane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5008-823X","authenticated-orcid":false,"given":"Adriano","family":"La Vecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3829-4254","authenticated-orcid":false,"given":"Gregorio Paolo","family":"Milani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"2152_CR1","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/S0140-6736(22)01016-9","volume":"400","author":"SR Dalziel","year":"2022","unstructured":"Dalziel SR, Haskell L, O\u2019Brien S, Borland ML, Plint AC, Babl FE, et al. Bronchiolitis Lancet. 2022;400:392\u2013406.","journal-title":"Bronchiolitis Lancet"},{"key":"2152_CR2","doi-asserted-by":"crossref","unstructured":"Sahai S, Bronchiolitis. Pediatr Care Online [Internet]. 2023 [cited 2025 June 9]; Available from: https:\/\/publications.aap.org\/pediatriccare\/article\/doi\/10.1542\/aap.ppcqr.396139\/1484\/Bronchiolitis.","DOI":"10.1542\/aap.ppcqr.396139"},{"key":"2152_CR3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/1824-7288-40-65","volume":"40","author":"E Baraldi","year":"2014","unstructured":"Baraldi E, Lanari M, Manzoni P, Rossi GA, Vandini S, Rimini A, et al. Inter-society consensus document on treatment and prevention of bronchiolitis in newborns and infants. Ital J Pediatr. 2014;40:65.","journal-title":"Ital J Pediatr"},{"key":"2152_CR4","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/S1473-3099(24)00176-2","volume":"24","author":"GBD 2021 Lower Respiratory Infections and Antimicrobial Resistance Collaborators","year":"2024","unstructured":"GBD 2021 Lower Respiratory Infections and Antimicrobial Resistance Collaborators. Global, regional, and National incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990\u20132021: a systematic analysis from the global burden of disease study 2021. Lancet Infect Dis. 2024;24:974\u20131002.","journal-title":"Lancet Infect Dis"},{"key":"2152_CR5","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1007\/s00431-023-05395-1","volume":"183","author":"GP Milani","year":"2024","unstructured":"Milani GP, Ronchi A, Agostoni C, Marchisio P, Chidini G, Pesenti N, et al. Long-lasting effects of COVID-19 pandemic on hospitalizations and severity of bronchiolitis. Eur J Pediatr. 2024;183:1751\u20138.","journal-title":"Eur J Pediatr"},{"key":"2152_CR6","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1542\/peds.2012-3877","volume":"132","author":"K Hasegawa","year":"2013","unstructured":"Hasegawa K, Tsugawa Y, Brown DFM, Mansbach JM, Camargo CA. Trends in bronchiolitis hospitalizations in the united States, 2000\u20132009. Pediatrics. 2013;132:28\u201336.","journal-title":"Pediatrics"},{"key":"2152_CR7","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1056\/NEJMoa1913556","volume":"383","author":"MP Griffin","year":"2020","unstructured":"Griffin MP, Yuan Y, Takas T, Domachowske JB, Madhi SA, Manzoni P, et al. Single-Dose nirsevimab for prevention of RSV in preterm infants. N Engl J Med. 2020;383:415\u201325.","journal-title":"N Engl J Med"},{"key":"2152_CR8","first-page":"181","volume":"83","author":"SJ Keam","year":"2023","unstructured":"Keam SJ, Nirsevimab. First Approval Drugs. 2023;83:181\u20137.","journal-title":"First Approval Drugs"},{"key":"2152_CR9","doi-asserted-by":"crossref","unstructured":"Ricc\u00f2 M, Cascio A, Corrado S, Bottazzoli M, Marchesi F, Gili R et al. Impact of nirsevimab immunization on pediatric hospitalization rates: a systematic review and meta-analysis (2024). Vaccines. 2024;12:640.","DOI":"10.3390\/vaccines12060640"},{"key":"2152_CR10","doi-asserted-by":"publisher","first-page":"e2024066584","DOI":"10.1542\/peds.2024-066584","volume":"154","author":"D Andina Mart\u00ednez","year":"2024","unstructured":"Andina Mart\u00ednez D, Claret Teruel G, Gij\u00f3n Mediavilla M, C\u00e1mara Otegui A, Ba\u00f1os L\u00f3pez L, De Miguel Lavisier B, et al. Nirsevimab and acute bronchiolitis episodes in pediatric emergency departments. Pediatrics. 2024;154:e2024066584.","journal-title":"Pediatrics"},{"key":"2152_CR11","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00431-025-06275-6","volume":"184","author":"A Villani","year":"2025","unstructured":"Villani A, Antilici L, Musolino AMC, Merola A, Perno CF, Raponi M, et al. RSV bronchiolitis: a disease only for those who do not receive prophylaxis. Eur J Pediatr. 2025;184:437.","journal-title":"Eur J Pediatr"},{"key":"2152_CR12","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1002\/ppul.23671","volume":"52","author":"C Lavagno","year":"2017","unstructured":"Lavagno C, Milani GP, Uestuener P, Simonetti GD, Casaulta C, Bianchetti MG, et al. Hyponatremia in children with acute respiratory infections: A reappraisal. Pediatr Pulmonol. 2017;52:962\u20137.","journal-title":"Pediatr Pulmonol"},{"key":"2152_CR13","first-page":"e368","volume":"105","author":"GP Milani","year":"2016","unstructured":"Milani GP, Plebani AM, Arturi E, Brusa D, Esposito S, Dell\u2019Era L, et al. Using a high-flow nasal cannula provided superior results to low-flow oxygen delivery in moderate to severe bronchiolitis. Acta Paediatr Oslo nor 1992. 2016;105:e368\u2013372.","journal-title":"Acta Paediatr Oslo nor 1992"},{"key":"2152_CR14","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/PEC.0000000000001145","volume":"35","author":"C Gong","year":"2019","unstructured":"Gong C, Byczkowski T, McAneney C, Goyal MK, Florin TA. Emergency department management of bronchiolitis in the united States. Pediatr Emerg Care. 2019;35:323\u20139.","journal-title":"Pediatr Emerg Care"},{"key":"2152_CR15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s40272-021-00488-6","volume":"24","author":"J Vila","year":"2022","unstructured":"Vila J, Lera E, Peremiquel-Trillas P, Mart\u00ednez L, Barcel\u00f3 I, Andr\u00e9s C, et al. Management of hospitalized respiratory syncytial virus bronchiolitis in the pediatric ward in spain: assessing the impact of a new clinical practice protocol. Paediatr Drugs. 2022;24:63\u201371.","journal-title":"Paediatr Drugs"},{"key":"2152_CR16","doi-asserted-by":"publisher","first-page":"S672","DOI":"10.1093\/infdis\/jiz240","volume":"222","author":"A Kirolos","year":"2020","unstructured":"Kirolos A, Manti S, Blacow R, Tse G, Wilson T, Lister M, et al. A systematic review of clinical practice guidelines for the diagnosis and management of bronchiolitis. J Infect Dis. 2020;222:S672\u20139.","journal-title":"J Infect Dis"},{"key":"2152_CR17","unstructured":"Lombardia - SICUPP [Internet]. SICUPP. 2025 [cited 2025 May 9]. [Internet]. Available from: https:\/\/sicupp.org\/la-societa\/sicupp-regionale\/lombardia\/."},{"key":"2152_CR18","unstructured":"Redazione. La variazione del numero di minori in Lombardia [Internet]. Openpolis. Fondazione openpolis; 2021 [cited 2025 May 9]. [Internet]. Available from: https:\/\/www.openpolis.it\/esercizi\/la-variazione-del-numero-di-minori-in-lombardia\/."},{"key":"2152_CR19","unstructured":"SISAC - Struttura Interregionale Sanitari Convenzionati [Internet]. Sisac.info. 2024 [cited 2025 May 9]. [Internet]. Available from: https:\/\/www.sisac.info\/ActionPagina_296.do."},{"key":"2152_CR20","doi-asserted-by":"publisher","first-page":"e2340082","DOI":"10.1001\/jamanetworkopen.2023.40082","volume":"6","author":"DJ Shapiro","year":"2023","unstructured":"Shapiro DJ, Bourgeois FT, Fine AM, Hersh AL, Coon ER, Neuman MI, et al. National patterns of outpatient Follow-Up visits after emergency care for acute bronchiolitis. JAMA Netw Open. 2023;6:e2340082.","journal-title":"JAMA Netw Open"},{"key":"2152_CR21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13052-023-01527-3","volume":"49","author":"F Porcaro","year":"2023","unstructured":"Porcaro F, Cutrera R, Vittucci AC, Villani A. Bronchiolitis guidelines: what about the Italian situation in a primary care setting? Ital J Pediatr. 2023;49:123.","journal-title":"Ital J Pediatr"},{"key":"2152_CR22","unstructured":"World Medical Association. WMA Declaration of Helsinki \u2013 Ethical Principles for Medical Research Involving Human Participants [Internet]. Wma.net. WMA - the World Medical Association-WMA Declaration of Helsinki \u2013 Ethical Principles for Medical Research Involving Human Participants. 2024. [Internet]. Available from: https:\/\/www.wma.net\/policies-post\/wma-declaration-of-helsinki\/."},{"key":"2152_CR23","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1093\/pch\/19.9.485","volume":"19","author":"JN Friedman","year":"2014","unstructured":"Friedman JN, Rieder MJ, Walton JM, Canadian Paediatric Society, Acute Care Committee. Drug therapy and hazardous substances Committee. Bronchiolitis: recommendations for diagnosis, monitoring and management of children one to 24 months of age. Paediatr Child Health. 2014;19:485\u201398.","journal-title":"Paediatr Child Health"},{"key":"2152_CR24","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1542\/peds.2014-1665","volume":"134","author":"MT COMMITTEE ON INFECTIOUS DISEASES AN","year":"2014","unstructured":"COMMITTEE ON INFECTIOUS DISEASES AND BRONCHIOLITIS GUIDELINES COMMITTEE, Brady MT, Byington CL, Davies HD, Edwards KM, Jackson MA, et al. Updated guidance for Palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics. 2014;134:415\u201320.","journal-title":"Pediatrics"},{"key":"2152_CR25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00134-022-06918-4","volume":"49","author":"C Mil\u00e9si","year":"2023","unstructured":"Mil\u00e9si C, Baudin F, Durand P, Emeriaud G, Essouri S, Pouyau R, et al. Clinical practice guidelines: management of severe bronchiolitis in infants under 12 months old admitted to a pediatric critical care unit. Intensive Care Med. 2023;49:5\u201325.","journal-title":"Intensive Care Med"},{"key":"2152_CR26","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1002\/iid3.451","volume":"9","author":"S Manti","year":"2021","unstructured":"Manti S, Licari A, Brambilla I, Caffarelli C, Calvani M, Cardinale F, et al. Agreements and controversies of National guidelines for bronchiolitis: results from an Italian survey. Immun Inflamm Dis. 2021;9:1229\u201336.","journal-title":"Immun Inflamm Dis"},{"key":"2152_CR27","first-page":"46","volume":"66","author":"R Megalaa","year":"2018","unstructured":"Megalaa R, Perez GF, Kilaikode-Cheruveettara S, Kotwal N, Rodriguez-Martinez CE, Nino G. Clinical definition of respiratory viral infections in young children and potential bronchiolitis misclassification. J Investig Med Off Publ Am Fed Clin Res. 2018;66:46\u201351.","journal-title":"J Investig Med Off Publ Am Fed Clin Res"},{"key":"2152_CR28","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13052-022-01392-6","volume":"49","author":"S Manti","year":"2023","unstructured":"Manti S, Staiano A, Orfeo L, Midulla F, Marseglia GL, Ghizzi C, et al. UPDATE \u2013\u20092022 Italian guidelines on the management of bronchiolitis in infants. Ital J Pediatr. 2023;49:19.","journal-title":"Ital J Pediatr"},{"key":"2152_CR29","doi-asserted-by":"publisher","first-page":"e2020040394","DOI":"10.1542\/peds.2020-040394","volume":"148","author":"KH Shanahan","year":"2021","unstructured":"Shanahan KH, Monuteaux MC, Nagler J, Bachur RG. Early use of bronchodilators and outcomes in bronchiolitis. Pediatrics. 2021;148:e2020040394.","journal-title":"Pediatrics"},{"key":"2152_CR30","doi-asserted-by":"publisher","first-page":"e059784","DOI":"10.1136\/bmjopen-2021-059784","volume":"12","author":"M-P Lirette","year":"2022","unstructured":"Lirette M-P, Kuppermann N, Finkelstein Y, Zemek R, Plint AC, Florin TA, et al. International variation in evidence-based emergency department management of bronchiolitis: a retrospective cohort study. BMJ Open. 2022;12:e059784.","journal-title":"BMJ Open"},{"key":"2152_CR31","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s13052-021-01148-8","volume":"47","author":"C Azzari","year":"2021","unstructured":"Azzari C, Baraldi E, Bonanni P, Bozzola E, Coscia A, Lanari M, et al. Epidemiology and prevention of respiratory syncytial virus infections in children in Italy. Ital J Pediatr. 2021;47:198.","journal-title":"Ital J Pediatr"},{"key":"2152_CR32","doi-asserted-by":"crossref","unstructured":"Bronchiolitis E. 2012 [cited 2025 July 8]. pp. 231\u2013235.e4. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9781437727029000337.","DOI":"10.1016\/B978-1-4377-2702-9.00033-7"},{"key":"2152_CR33","doi-asserted-by":"publisher","first-page":"e20193684","DOI":"10.1542\/peds.2019-3684","volume":"146","author":"A Zipursky","year":"2020","unstructured":"Zipursky A, Kuppermann N, Finkelstein Y, Zemek R, Plint AC, Babl FE, et al. International practice patterns of antibiotic therapy and laboratory testing in bronchiolitis. Pediatrics. 2020;146:e20193684.","journal-title":"Pediatrics"},{"key":"2152_CR34","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1136\/adc.81.3.231","volume":"81","author":"AS El-Radhi","year":"1999","unstructured":"El-Radhi AS, Barry W, Patel S. Association of fever and severe clinical course in bronchiolitis. Arch Dis Child. 1999;81:231\u20134.","journal-title":"Arch Dis Child"},{"key":"2152_CR35","doi-asserted-by":"publisher","first-page":"2333794X1986866","DOI":"10.1177\/2333794X19868660","volume":"6","author":"D Elmore","year":"2019","unstructured":"Elmore D, Yaslam B, Putty K, Magrane T, Abadir A, Bhatt S, et al. Is fever a red flag for bacterial pneumonia in children with viral bronchiolitis? Glob Pediatr Health. 2019;6:2333794X19868660.","journal-title":"Glob Pediatr Health"},{"key":"2152_CR36","doi-asserted-by":"publisher","first-page":"549","DOI":"10.3390\/vaccines12050549","volume":"12","author":"A Consolati","year":"2024","unstructured":"Consolati A, Farinelli M, Serravalle P, Rollandin C, Apprato L, Esposito S, et al. Safety and efficacy of nirsevimab in a universal prevention program of respiratory syncytial virus bronchiolitis in newborns and infants in the first year of life in the Valle d\u2019aosta Region, Italy, in the 2023\u20132024 epidemic season. Vaccines. 2024;12:549.","journal-title":"Vaccines"},{"key":"2152_CR37","doi-asserted-by":"publisher","first-page":"102986","DOI":"10.1016\/j.eclinm.2024.102986","volume":"79","author":"C Ocana de Sentuary","year":"2025","unstructured":"Ocana de Sentuary C, Testard C, Lagr\u00e9e M, Leroy M, Gasnier L, Enes-Dias A, et al. Acceptance and safety of the RSV-preventive treatment of newborns with nirsevimab in the maternity department: a prospective longitudinal cohort study in France. EClinicalMedicine. 2025;79:102986.","journal-title":"EClinicalMedicine"},{"key":"2152_CR38","doi-asserted-by":"publisher","first-page":"S158","DOI":"10.1097\/INF.0000000000004632","volume":"44","author":"S Paulson","year":"2025","unstructured":"Paulson S, Munro APS, Cathie K, Bedford H, Jones CE. Protecting against respiratory syncytial virus: an online questionnaire study exploring UK parents\u2019 acceptability of vaccination in pregnancy or monoclonal antibody administration for infants. Pediatr Infect Dis J. 2025;44:S158\u201361.","journal-title":"Pediatr Infect Dis J"},{"key":"2152_CR39","doi-asserted-by":"publisher","first-page":"S282","DOI":"10.1093\/infdis\/jiac216","volume":"226","author":"A Kieffer","year":"2022","unstructured":"Kieffer A, Beuvelet M, Sardesai A, Musci R, Milev S, Roiz J, et al. Expected impact of universal immunization with nirsevimab against RSV-Related outcomes and costs among all US infants in their first RSV season: A static model. J Infect Dis. 2022;226:S282\u201392.","journal-title":"J Infect Dis"},{"key":"2152_CR40","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1475-6773.2005.00350.x","volume":"40","author":"WL Cull","year":"2005","unstructured":"Cull WL, O\u2019Connor KG, Sharp S, Tang SS. Response rates and response bias for 50 surveys of pediatricians. Health Serv Res. 2005;40:213\u201326.","journal-title":"Health Serv Res"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-025-02152-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-025-02152-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-025-02152-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T13:12:29Z","timestamp":1781615549000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13052-025-02152-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2152"],"URL":"https:\/\/doi.org\/10.1186\/s13052-025-02152-y","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"29 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all participants, and no personally identifiable information was collected, thereby ensuring participant anonymity. According to current Italian legislation, observational studies based on anonymous survey data and not involving patients directly do not require approval from an ethics committee (Article 110, Italian Data Protection Code, as amended by the \u2018PNRR bis\u2019 decree).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"305"}}